Research and Development 2021

Views & Analysis
Digitalising drug discovery

Digitalising drug discovery

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is ver

Views & Analysis
The landscape for UK R&D SMEs post-COVID

The landscape for UK R&D SMEs post-COVID

Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has enabled the UK to respond swiftly to the pandemic.